Discussions around healthcare spending have been ignored for decades, but Robert Dubois, MD, PhD, chief science officer and executive vice president at National Pharmaceutical Council, believes we have the ability to start those discussions now.
Discussions around healthcare spending have been ignored for decades, but Robert Dubois, MD, PhD, chief science officer and executive vice president at National Pharmaceutical Council, believes we have the ability to start those discussions now.
Transcript
In the United States we have typically avoided difficult healthcare spending discussions. How vital are these discussions and why do you believe they can be done?
Well, I think it’s vital that we begin to have a discussion around healthcare spending. We’ve kicked the can down the road for several decades now and problems are getting worse and worse. Whether you look at the percentage of GDP that’s spent on healthcare—if you look at the cost of health premiums—if you look at the impact of premiums on wages, whether states can provide funds for education or road repair. All of these things are crowding out because of what’s going on in the healthcare spending arena. The problem also is that the longer we delay, the more draconian the changes and the interventions are going to need to be. Medicare trust fund is going to expire in the next 6-8 years and the types of changes that are going to be required are going to be really tough if we push this off much further. Now, the next obvious question is can we actually talk about tough issues like healthcare spending—I actually believe we can. We’ve begun a series of town hall dialogues in local communities. We’ve had 1 in Nashville and 1 in Raleigh and we’ve brought local people together to talk about healthcare spending and the issues related to that—and we’ve got 6 more of these queued up. So, I'm actually quite optimistic that we can have the discussion and I’m absolutely convinced that we must have the discussion.
ATS 2024: Bridging the Past, Present, and Future of Respiratory Care
May 16th 2024The application of artificial intelligence in medicine is anticipated as a highlight of ATS 2024, with sessions exploring its applications in research, radiological interpretation, and pediatric pulmonology.
Read More
Frameworks for Advancing Health Equity: Urban Health Outreach
May 9th 2024In the series debut episode of "Frameworks for Advancing Health Equity," Mary Sligh, CRNP, and Chelsea Chappars, of Allegheny Health Network, explain how the Urban Health Outreach program aims to improve health equity for individuals experiencing homelessness.
Listen
Tackling Health Inequality: The Power of Education and Experience
April 30th 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. Welcome to our final episode of this limited series and our conversation with Janine Jelks-Seale, MSPPM, director of health equity at UPMC Health Plan.
Listen
Looking Back on ISPOR 2024: Hot Policy Topics, Welcome Focus on Employers, and More
May 10th 2024Kimberly Westrich, MA, chief strategy officer of the National Pharmaceutical Council, reflects on the most valuable learnings from the 2024 meeting of ISPOR—The Professional Society for Health Economics and Outcomes Research, including lively discussions of the Inflation Reduction Act and workshops on value assessment.
Read More